These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10956220)

  • 1. Synthesis and structure-activity relationships of a new set of 2-arylpyrazolo[3,4-c]quinoline derivatives as adenosine receptor antagonists.
    Colotta V; Catarzi D; Varano F; Cecchi L; Filacchioni G; Martini C; Trincavelli L; Lucacchini A
    J Med Chem; 2000 Aug; 43(16):3118-24. PubMed ID: 10956220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1,2,4-Triazolo[4,3-a]quinoxalin-1-one: a versatile tool for the synthesis of potent and selective adenosine receptor antagonists.
    Colotta V; Catarzi D; Varano F; Cecchi L; Filacchioni G; Martini C; Trincavelli L; Lucacchini A
    J Med Chem; 2000 Mar; 43(6):1158-64. PubMed ID: 10737748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and structure-activity relationships of a new set of 1,2,4-triazolo[4,3-a]quinoxalin-1-one derivatives as adenosine receptor antagonists.
    Colotta V; Catarzi D; Varano F; Filacchioni G; Martini C; Trincavelli L; Lucacchini A
    Bioorg Med Chem; 2003 Aug; 11(16):3541-50. PubMed ID: 12878146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New 2-arylpyrazolo[3,4-c]quinoline derivatives as potent and selective human A3 adenosine receptor antagonists. Synthesis, pharmacological evaluation, and ligand-receptor modeling studies.
    Colotta V; Catarzi D; Varano F; Capelli F; Lenzi O; Filacchioni G; Martini C; Trincavelli L; Ciampi O; Pugliese AM; Pedata F; Schiesaro A; Morizzo E; Moro S
    J Med Chem; 2007 Aug; 50(17):4061-74. PubMed ID: 17665891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1,2,4-Triazolo[1,5-a]quinoxaline derivatives: synthesis and biological evaluation as adenosine receptor antagonists.
    Catarzi D; Colotta V; Varano F; Filacchioni G; Martini C; Trincavelli L; Lucacchini A
    Farmaco; 2004 Feb; 59(2):71-81. PubMed ID: 14871498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, CoMFA analysis, and receptor docking of 3,5-diacyl-2, 4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists.
    Li AH; Moro S; Forsyth N; Melman N; Ji XD; Jacobson KA
    J Med Chem; 1999 Feb; 42(4):706-21. PubMed ID: 10052977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-aryl-8-chloro-1,2,4-triazolo[1,5-a]quinoxalin-4-amines as highly potent A1 and A3 adenosine receptor antagonists.
    Catarzi D; Colotta V; Varano F; Calabri FR; Lenzi O; Filacchioni G; Trincavelli L; Martini C; Tralli A; Montopoli C; Moro S
    Bioorg Med Chem; 2005 Feb; 13(3):705-15. PubMed ID: 15653338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and biological evaluation of C9- and C2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as new A2A and A3 adenosine receptors antagonists.
    Baraldi PG; Fruttarolo F; Tabrizi MA; Preti D; Romagnoli R; El-Kashef H; Moorman A; Varani K; Gessi S; Merighi S; Borea PA
    J Med Chem; 2003 Mar; 46(7):1229-41. PubMed ID: 12646033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New 2-arylpyrazolo[4,3-c]quinoline derivatives as potent and selective human A3 adenosine receptor antagonists.
    Baraldi PG; Tabrizi MA; Preti D; Bovero A; Fruttarolo F; Romagnoli R; Zaid NA; Moorman AR; Varani K; Borea PA
    J Med Chem; 2005 Jul; 48(15):5001-8. PubMed ID: 16033279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel class of adenosine A3 receptor ligands. 1. 3-(2-Pyridinyl)isoquinoline derivatives.
    van Muijlwijk-Koezen JE; Timmerman H; Link R; van der Goot H; IJzerman AP
    J Med Chem; 1998 Oct; 41(21):3987-93. PubMed ID: 9767636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, biological activity, and molecular modeling investigation of new pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as human A(3) adenosine receptor antagonists.
    Baraldi PG; Cacciari B; Moro S; Spalluto G; Pastorin G; Da Ros T; Klotz KN; Varani K; Gessi S; Borea PA
    J Med Chem; 2002 Feb; 45(4):770-80. PubMed ID: 11831890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, structure-affinity relationships, and molecular modeling studies of novel pyrazolo[3,4-c]quinoline derivatives as adenosine receptor antagonists.
    Lenzi O; Colotta V; Catarzi D; Varano F; Squarcialupi L; Filacchioni G; Varani K; Vincenzi F; Borea PA; Dal Ben D; Lambertucci C; Cristalli G
    Bioorg Med Chem; 2011 Jun; 19(12):3757-68. PubMed ID: 21616671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological activities of flavonoid derivatives as A3 adenosine receptor antagonists.
    Karton Y; Jiang JL; Ji XD; Melman N; Olah ME; Stiles GL; Jacobson KA
    J Med Chem; 1996 Jun; 39(12):2293-301. PubMed ID: 8691424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships of 4-(phenylethynyl)-6-phenyl-1,4-dihydropyridines as highly selective A3 adenosine receptor antagonists.
    Jiang J; van Rhee AM; Chang L; Patchornik A; Ji XD; Evans P; Melman N; Jacobson KA
    J Med Chem; 1997 Aug; 40(16):2596-608. PubMed ID: 9258367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thiazole and thiadiazole analogues as a novel class of adenosine receptor antagonists.
    van Muijlwijk-Koezen JE; Timmerman H; Vollinga RC; Frijtag von Drabbe Künzel J; de Groote M; Visser S; IJzerman AP
    J Med Chem; 2001 Mar; 44(5):749-62. PubMed ID: 11262085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isoquinoline and quinazoline urea analogues as antagonists for the human adenosine A(3) receptor.
    van Muijlwijk-Koezen JE; Timmerman H; van der Goot H; Menge WM; Frijtag Von Drabbe Künzel J; de Groote M; IJzerman AP
    J Med Chem; 2000 Jun; 43(11):2227-38. PubMed ID: 10841801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of 4-amino-6-(hetero)arylalkylamino-1,2,4-triazolo[4,3-a]quinoxalin-1-one derivatives as potent A(2A) adenosine receptor antagonists.
    Colotta V; Catarzi D; Varano F; Filacchioni G; Martini C; Trincavelli L; Lucacchini A
    Bioorg Med Chem; 2003 Dec; 11(24):5509-18. PubMed ID: 14642595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives as highly potent and selective human A(3) adenosine receptor antagonists: influence of the chain at the N(8) pyrazole nitrogen.
    Baraldi PG; Cacciari B; Romagnoli R; Spalluto G; Moro S; Klotz KN; Leung E; Varani K; Gessi S; Merighi S; Borea PA
    J Med Chem; 2000 Dec; 43(25):4768-80. PubMed ID: 11123985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new series of 2-alkoxy(aralkoxy)-[1,2,4]triazolo[1,5-a]quinazolin-5-ones as adenosine receptor antagonists.
    Al-Salahi R; Geffken D; Koellner M
    Chem Pharm Bull (Tokyo); 2011; 59(6):730-3. PubMed ID: 21628909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4-amido-2-aryl-1,2,4-triazolo[4,3-a]quinoxalin-1-ones as new potent and selective human A3 adenosine receptor antagonists. synthesis, pharmacological evaluation, and ligand-receptor modeling studies.
    Lenzi O; Colotta V; Catarzi D; Varano F; Filacchioni G; Martini C; Trincavelli L; Ciampi O; Varani K; Marighetti F; Morizzo E; Moro S
    J Med Chem; 2006 Jun; 49(13):3916-25. PubMed ID: 16789747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.